In addition, cartridges that are able to detect the most relevant genetic alterations of both the BRAF and NRAS genes in a single assay are now available, and they can be also used in other tumors harboring such alterations (i.e., colorectal cancer) [33]. This evidence concerns the gene BRAF and colorectal cancer.